ArticleThe British journal of cardiology2025
The eye as a window to CVD: case series and literature review of retinal ischaemic perivascular lesion (RIPL).
Article in The British journal of cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Use of retinal ischemic perivascular lesions (RIPLS) as a biomarker for cardiovascular disease - a systematic review and meta-analysis.International journal of retina and vitreous · 2025Review
- Retinal Ischemic Perivascular Lesions (RIPLs) as Potential Biomarkers for Systemic Vascular Diseases: A Narrative Review of the Literature.Ophthalmology and therapy · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal ischaemic perivascular lesions (RIPL) are characterised on spectral domain optical coherence tomography (SD-OCT) as focal thinning of the inner nuclear layer (INL) associated with outer nuclear layer (ONL) upward expansion. We present a small case series of 11 patients and reviewed all relevant original research on RIPL and its association with cardiovascular diseases (CVD). All 11 patients had RIPL incidentally identified on SD-OCT by two consultant ophthalmologists during a routine medical retina clinic. We obtained a thorough medical history to identify risk factors and CVD. The most common risk factor was type 2 diabetes mellitus (90.9%), followed by hypertension (81.9%). A diagnosis of arrhythmia was determined in 36.4% patients, coronary artery disease in 27.3%, cerebrovascular events in 36.4%, peripheral vascular disease in 27.3% and carotid artery stenosis in 8.3%. A literature search was conducted using PubMed, Google Scholar and Scopus, using all relevant key words. Seven pieces of original research were described in the literature. Six of these described a RIPL prevalence ranging from 34.62% to 91%. One paper described a case series with an incidence of 72.7% new diagnosis of CVD in their cohort who were identified to have RIPLs. The ophthalmologists' role in detecting RIPLs could be used to assess cardiovascular risk status, supporting a multi-disciplinary approach in managing CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.